MAPT and Alzheimer disease: PET scans have made it possible to detect these pathological changes which are considered essential to biologically define AD, per the most recent research framework proposed by the National Institute on Aging and Alzheimer’s Association (NIA-AA) the Amyloid Tau Neurodegeneration [ATN] framework (13, 14).